Login / Signup

Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma.

Takashi NakagawaToshiki KijimaNaoki ImasatoAkihiko NagoshiGaku NakamuraToshitaka UematsuIssei SuzukiDaisaku NishiharaTakao Kamai
Published in: IJU case reports (2022)
Cabozantinib, alone or in combination with immune checkpoint inhibitors, may be a viable option for clear cell renal cell carcinoma with brain metastases.
Keyphrases
  • brain metastases
  • small cell lung cancer
  • renal cell carcinoma
  • metastatic renal cell carcinoma